rifampin and Uterine-Cervical-Neoplasms

Tuberculosis of the cervix is a rare disease and accounts for 0.1-0.65% of all cases of tuberculosis. We present an unusual case of a 57 years old female who presented with chief complaints of Serosaguineous vaginal discharge of one year duration and irregular firm cervix with contact bleeding and was clinically diagnosed to have cervical cancer. Histopathology revealed typical findings of cervical tuberculosis. Cervical tuberculosis should be considered as a differential diagnosis of cervical malignancy. The clinical presentation and diagnosis of cervical tuberculosis is reviewed.

Topics: Antitubercular Agents; Cervix Uteri; Diagnosis, Differential; Ethambutol; Female; Gynecological Examination; Humans; Middle Aged; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Female Genital; Ultrasonography; Uterine Cervical Neoplasms

Topics: Adult; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Metronidazole; Nystatin; Precancerous Conditions; Rifampin; Tetracycline; Uterine Cervical Neoplasms

Topics: Cell Division; Cell Line; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation, Preclinical; Female; Fibroblasts; Humans; Melanoma; Neoplasms; Osteosarcoma; Rifampin; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms

Topics: Adult; Carcinoma in Situ; Carcinoma, Squamous Cell; Colposcopy; Cytodiagnosis; Female; Humans; Rifampin; Uterine Cervical Neoplasms

Topics: Adult; Colposcopy; Female; Humans; Remission, Spontaneous; Rifampin; Uterine Cervical Neoplasms